SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000919574-19-005970
Filing Date
2019-09-20
Accepted
2019-09-20 12:45:50
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8374462_13d-a.htm SC 13D/A 95496
  Complete submission text file 0000919574-19-005970.txt   97380
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Subject) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-43381 | Film No.: 191103512
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 TICE BLVD SUITE 140 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD SUITE 140 WOODCLIFF LAKE NJ 07677 212-488-5411
Healthcare Value Capital, LLC (Filed by) CIK: 0001458461 (see all company filings)

IRS No.: 320251223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A